相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
Gaia Giannone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Phosphoproteomic Profiling Identifies Aberrant Activation of Integrin Signaling in Aggressive Non-Type Bladder Carcinoma
Barnali Deb et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors
Synnove Nymark Aasen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Kinase-targeted cancer therapies: progress, challenges and future directions
Khushwant S. Bhullar et al.
MOLECULAR CANCER (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
Targeting the cell cycle in breast cancer: towards the next phase
K. L. Thu et al.
CELL CYCLE (2018)
Structure-guided design of purine-based probes for selective Nek2 inhibition
Christopher R. Coxon et al.
ONCOTARGET (2017)
Protein Kinase Targets in Breast Cancer
Marilina Garcia-Aranda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Phosphorylation: Implications in Cancer
Vishakha Singh et al.
PROTEIN JOURNAL (2017)
The target landscape of clinical kinase drugs
Susan Klaeger et al.
SCIENCE (2017)
Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis
Lea Landolt et al.
PHYSIOLOGICAL REPORTS (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
Kinase inhibitors and monoclonal antibodies in oncology: clinical implications
Helen Gharwan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer
Justin M. Drake et al.
CELL (2016)
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Hui Zhang et al.
CELL (2016)
Targeting NEK2 as a promising therapeutic approach for cancer treatment
Yanfen Fang et al.
CELL CYCLE (2016)
Multi-kinase inhibitors, AURKs and cancer
Jonas Cicenas et al.
MEDICAL ONCOLOGY (2016)
Proteogenomics connects somatic mutations to signalling in breast cancer
Philipp Mertins et al.
NATURE (2016)
Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patient
Eva Dazert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Aurora kinase A gene copy number is associated with the malignant transformation of colorectal adenomas but not with the serrated neoplasia progression
Laura Casorzo et al.
HUMAN PATHOLOGY (2015)
Aurora kinase A in gastrointestinal cancers: time to target
Ahmed Katsha et al.
MOLECULAR CANCER (2015)
Role of NEK2A in Human Cancer and Its Therapeutic Potentials
Jiliang Xia et al.
BIOMED RESEARCH INTERNATIONAL (2015)
A unique presentation of a renal clear cell carcinoma with atypical metastases
F. Staderini et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2015)
Roscovitine in cancer and other diseases
Jonas Cicenas et al.
ANNALS OF TRANSLATIONAL MEDICINE (2015)
Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
Jie Xu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion
T-V Do et al.
ONCOGENE (2014)
BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma
Ben Davidson et al.
VIRCHOWS ARCHIV (2014)
Highlights of the Latest Advances in Research on CDK Inhibitors
Jonas Cicenas et al.
CANCERS (2014)
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
Andrea Franceschini et al.
NUCLEIC ACIDS RESEARCH (2013)
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
Sophia Y. Lunt et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The CDK inhibitors in cancer research and therapy
Jonas Cicenas et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Survivin-Induced Aurora-B Kinase Activation A Mechanism by Which APC Mutations Contribute to Increased Mitoses during Colon Cancer Development
Tao Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Dissecting the M Phase-specific Phosphorylation of Serine-Proline or Threonine-Proline Motifs
Chuan Fen Wu et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
Structure and regulation of the human Nek2 centrosomal kinase
Peter Rellos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Discovery of N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays
LJ Lombardo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Cell cycle genes in ovarian cancer: Steps toward earlier diagnosis and novel therapies
G D'Andrilli et al.
CLINICAL CANCER RESEARCH (2004)
Overriding imatinib resistance with a novel ABL kinase inhibitor
NP Shah et al.
SCIENCE (2004)
分享论文
